
Tirzepatide
20 mg
HPLC
99.5%
CoA
On file
Batch
Verified
Metabolic Research
Tirzepatide (20mg)
SKU: FSX-021-20MG
$249.99
AUD · per vial · 20 mg
Tirzepatide is a dual-agonist research peptide widely studied in metabolic pathway research. HPLC verified, lyophilised. For in-vitro laboratory research only.
1
Same-day dispatch
Mon–Fri before 12pm AEST
Published CoA
Linked to your batch ID
Lost/damaged cover
Resend or store credit
99%+ HPLC purity
Third-party verified
Research Use Only: Not for human or veterinary consumption. Sold exclusively for in-vitro laboratory research to qualified researchers aged 18+.
Related Compounds
View all
Retatrutide
10 mg
In Stock
99.4% HPLC · 10 mg
Retatrutide (10mg)
Triple-agonist research peptide (GLP-1 / GIP / glucagon).
$144.99

Retatrutide
20 mg
Out of Stock
99.4% HPLC · 20 mg
Retatrutide (20mg)
Higher-capacity triple-agonist research vial.
$229.99

Retatrutide
30 mg
In Stock
99.4% HPLC · 30 mg
Retatrutide (30mg)
Triple-agonist research peptide, 30mg vial.
$329.99

Tirzepatide
40 mg
In Stock
Save $8699.5% HPLC · 40 mg
Tirzepatide (40mg)
Dual-agonist research compound, value vial.
$429.99$343.99